IGFALS gene dosage effects on serum IGF-I and glucose metabolism, body composition, bone growth in length and width, and the pharmacokinetics of recombinant human IGF-I administration

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 4, 2014, Pages

  Högler, Wolfgang ^a   Martin, David D ^b   Crabtree, Nicola ^a   Nightingale, Peter ^c   Tomlinson, Jeremy ^d   Metherell, Lou ^e   Rosenfeld, Ron ^f   Hwa, Vivian ^k   Rose, Stephen ^g   Walker, Joanna ^h   Shaw, Nicholas ^a   Barrett, Timothy ^a,d   Frystyk, Jan ^i,j  

^a BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^e QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^f OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^g BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

^h PORTSMOUTH HOSPITALS NHS TRUST   (United Kingdom)

ⁱ AARHUS UNIVERSITY   (Denmark)

^j AARHUS UNIVERSITY HOSPITAL   (Denmark)

^k Department of Endocrinology and Internal Medicine Aarhus University Hospital ^*

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; BLOOD GLUCOSE; BODY COMPOSITION; BONE DENSITY; BONE DEVELOPMENT; CARRIER PROTEINS; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; GENE DOSAGE; GLYCOPROTEINS; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MIDDLE AGED; RECOMBINANT PROTEINS; YOUNG ADULT;

EID: 84898444840     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-3718     Document Type: Article

References (56)

1. Domene HM, Bengolea SV, Martinez AS, et al. Deficiency of the circulating insulin-like growth factor system associated with inactivation of the acid-labile subunit gene. NEngl J Med . 2004;350(6): 570-577.
2. Domene HM, Hwa V, Argente J, et al. Human acid-labile subunit deficiency: clinical, endocrine and metabolic consequences. Horm Res . 2009;72(3):129-141.
3. Domene HM, Hwa V, Jasper HG, Rosenfeld RG. Acid-labile subunit (ALS) deficiency. Best Pract Res Clin Endocrinol Metab . 2011; 25(1):101-113.
4. Backeljauw PF, Chernausek SD. The insulin-like growth factors and growth disorders of childhood. Endocrinol Metab Clin North Am . 2012;41(2):265-282.
5. DomeneHM,Scaglia PA, Lteif A, et al. Phenotypic effects of null and haploinsufficiency of acid-labile subunit in a family with two novel IGFALS gene mutations. J Clin Endocrinol Metab . 2007;92(11): 4444-4450.
6. Heath KE, Argente J, Barrios V, et al. Primary acid-labile subunit deficiency due to recessive IGFALS mutations results in postnatal growth deficit associated with low circulating insulin growth factor (IGF)-I, IGF binding protein-3 levels, and hyperinsulinemia. J Clin Endocrinol Metab . 2008;93(5):1616-1624.
7. Hess O, Khayat M, Hwa V, et al. A novel mutation in IGFALS, c. 380T-C (p.L127P), associated with short stature, delayed puberty, osteopenia and hyperinsulinaemia in two siblings: insights into the roles of insulin growth factor-1 (IGF1). Clin Endocrinol (Oxf). 2013;79(6):838-844.
8. van Duyvenvoorde HA, Kempers MJ, Twickler TB, et al. Homozygous and heterozygous expression of a novel mutation of the acidlabile subunit. Eur J Endocrinol . 2008;159(2):113-120.
9. Domene HM, Bengolea SV, Jasper HG, Boisclair YR. Acid-labile subunit deficiency: phenotypic similarities and differences between human and mouse. J Endocrinol Invest. 2005;28(suppl 5):43-46.
10. Fofanova-Gambetti OV, Hwa V, Wit JM, et al. Impact of heterozygosity for acid-labile subunit (IGFALS) gene mutations on stature: results from the international acid-labile subunit consortium. J Clin Endocrinol Metab . 2010;95(9):4184-4191.
11. Freeman JV, Cole TJ, Chinn S, Jones PR, White EM, Preece MA. Cross sectional stature and weight reference curves for the UK, 1990. Arch Dis Child . 1995;73(1):17-24.
12. Cole TJ, Freeman JV, Preece MA. Body mass index reference curves for the UK, 1990. Arch Dis Child . 1995;73(1):25-29.
13. Fofanova-Gambetti OV, Hwa V, Kirsch S, et al. Three novel IGFALS gene mutations resulting in total ALS and severe circulating IGF-I/IGFBP-3 deficiency in children of different ethnic origins. Horm Res . 2009;71(2):100-110.
14. David A, Rose SJ, Miraki-Moud F, et al. Acid-labile subunit deficiency and growth failure: description of two novel cases. Horm Res Paediatr . 2010;73(5):328-334.
15. Frystyk J, Skjaerbaek C, Dinesen B, Orskov H. Free insulin-like growth factors (IGF-I and IGF-II) inhumanserum. FEBSLett . 1994; 348(2):185-191.
16. Frystyk J, Dinesen B, Orskov H. Non-competitive time-resolved immunofluorometric assays for determination of human insulinlike growth factor I and II. Growth Regul . 1995;5(4):169-176.
17. Heinze E, Holl RW. Tests of -cell function in childhood and adolescence. In: Ranke MB, Mullis PE, eds. Diagnostics of Endocrine Function in Children and Adolescents. Basel: Karger, 2003:318-338.
18. American Diabetes Association. Standards of medical care in diabetes-2013. Diabetes Care. 2013;36(suppl 1):S11-S66.
19. Lee JM, Okumura MJ, Davis MM, Herman WH, Gurney JG. Prevalence and determinants of insulin resistance among US adolescents: a population-based study. Diabetes Care . 2006;29(11):2427-2432.
20. Levy JC, Matthews DR, Hermans MP. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care . 1998;21(12):2191-2192.
21. Kadam N, Khadilkar A, Chiplonkar S, Khadilkar V, Mughal Z. Variation in lumbar spine bone mineral content by age and gender in apparently healthy Indians. J Bone Miner Metab . 2009;27(6): 705-712.
22. Fan B, Shepherd JA, Levine MA, et al. National Health and Nutrition Examination Survey whole-body dual-energy x-ray absorptiometry reference data for GE Lunar systems [published online October 22, 2013]. J Clin Densitom. doi:10.1016/j.jocd.2013.08.019.
23. Rauch F, Schoenau E. Peripheral quantitative computed tomography of the distal radius in young subjects-new reference data and interpretation of results. J Musculoskelet Neuronal Interact . 2005; 5(2):119-126.
24. Rauch F, Schoenau E. Peripheral quantitative computed tomography of the proximal radius in young subjects-new reference data and interpretation of results. J Musculoskelet Neuronal Interact . 2008;8(3):217-226.
25. Sergi G, Perissinotto E, Zucchetto M, et al. Upper limb bone mineral density and body composition measured by peripheral quantitative computed tomography in right-handed adults: the role of the dominance effect. J Endocrinol Invest . 2009;32(4):298-302.
26. Wilks DC, Winwood K, Gilliver SF, et al. Bone mass and geometry of the tibia and the radius of master sprinters, middle and long distance runners, race-walkers and sedentary control participants: a pQCT study. Bone . 2009;45(1):91-97.
27. Martin DD, Heckmann C, Jenni OG, Ranke MB, Binder G, Thodberg HH. Metacarpal thickness, width, length and medullary diameter in children-reference curves from the First Zurich Longitudinal Study. Osteoporos Int . 2011;22(5):1525-1536.
28. Bottcher J, Pfeil A, Schafer ML, et al. Normative data for digital X-ray radiogrammetry from a female and male German cohort. J Clin Densitom . 2006;9(3):341-350.
29. Thodberg HH, van Rijn RR, Tanaka T, Martin DD, Kreiborg S. A paediatric bone index derived by automated radiogrammetry. Osteoporos Int . 2010;21(8):1391-1400.
30. Guevara-Aguirre J, Liao S, Hsieh F, Saavedra J, Guevara M, Bright G. A pharmacokinetic study to assess dosing requirements for recombinant human IGF-1 in patients with primary IGF-1 deficiency. Paper presented at: 12th International Conference of Endocrinology; Lisbon, Portugal; August 31-September 4, 2004 (Abstract P1052).
31. Kirsch S, Koltin D, Hamilton J. Continuous s.c. nightly infusion if IGF-1 stimulates growth in acid labile subunit deficiency. HormRes. 2009;72(suppl 3):200-201.
32. Clemmons DR. Metabolic actions of insulin-like growth factor-I in normal physiology and diabetes. Endocrinol Metab Clin NorthAm . 2012;41(2):425-443.
33. Wit JM, Oostdijk W, Losekoot M. Spectrum of insulin-like growth factor deficiency. Endocr Dev . 2012;23:30-41.
34. Guevara-Aguirre J, Balasubramanian P, Guevara-Aguirre M, et al. Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans. Sci Transl Med. 2011;3(70):70ra13.
35. Agladioglu SY, Cetinkaya S, Erdeve SS, et al. Diabetes mellitus with Laron syndrome: case report. J Pediatr Endocrinol Metab . 2013; 26(9-10):955-958.
36. Laron Z, Weinberger D. Diabetic retinopathy in two patients with congenital IGF-I deficiency (Laron syndrome). Eur J Endocrinol . 2004;151(1):103-106.
37. FernandezAM,KimJK, Yakar S, et al. Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes. Genes Dev . 2001;15(15):1926-1934.
38. Kulkarni RN, Holzenberger M, Shih DQ, et al. -Cell-specific deletion of the Igf1 receptor leads to hyperinsulinemia and glucose intolerance but does not alter -cell mass. Nat Genet . 2002;31(1): 111-115.
39. Xuan S, Kitamura T, Nakae J, et al. Defective insulin secretion in pancreatic - cells lacking type 1 IGF receptor. J Clin Invest . 2002; 110(7):1011-1019.
40. Yakar S, Liu JL, Fernandez AM, et al. Liver-specific IGF-1 gene deletion leads to muscle insulin insensitivity. Diabetes . 2001;50(5): 1110-1118.
41. Yakar S, Rosen CJ, Beamer WG, et al. Circulating levels of IGF-1 directly regulate bone growth and density. J Clin Invest . 2002; 110(6):771-781.
42. Sjogren K, Wallenius K, Liu JL, et al. Liver-derived IGF-I is of importance for normal carbohydrate and lipid metabolism. Diabetes . 2001;50(7):1539-1545.
43. Clemmons DR, Smith-Banks A, Underwood LE. Reversal of dietinduced catabolism by infusion of recombinant insulin-like growth factor-I in humans. J Clin Endocrinol Metab . 1992;75(1):234-238.
44. Wu Y, Sun H, Basta-Pljakic J, et al. Serum IGF-1 is insufficient to restore skeletal size in the total absence of the growth hormone receptor. J Bone Miner Res . 2013;28(7):1575-1586.
45. Haluzik M, Yakar S, Gavrilova O, Setser J, Boisclair Y, Leroith D. Insulin resistance in the liver-specific IGF-1 gene-deleted mouse is abrogated by deletion of the acid-labile subunit of the IGF-binding protein-3 complex: relative roles of growth hormone and IGF-1 in insulin resistance. Diabetes . 2003;52(10):2483-2489.
46. Yakar S, Rosen CJ, Bouxsein ML, et al. Serum complexes of insulinlike growth factor-1 modulate skeletal integrity and carbohydrate metabolism. FASEB J . 2009;23(3):709-719.
47. Courtland HW, DeMambro V, Maynard J, et al. Sex-specific regulation of body size and bone slenderness by the acid labile subunit. J Bone Miner Res . 2010;25(9):2059-2068.
48. Rensing KL, van Duyvenvoorde HA, Cramer MJ, et al. Case report: low circulating IGF-I levels due to acid-labile subunit deficiency in adulthood are not associated with early development of atherosclerosis and impaired heart function. Growth Horm IGF Res . 2011; 21(4):233-237.
49. Bachrach LK, Sills IN. Clinical report-bone densitometry in children and adolescents. Pediatrics . 2011;127(1):189-194.
50. Ḧgler W, Shaw N. Childhood growth hormone deficiency, bone density, structures and fractures: scrutinizing the evidence. Clin Endocrinol (Oxf) . 2010;72(3):281-289.
51. Frost HM. The mechanostat: a proposed pathogenic mechanism of osteoporosis and the bone mass effects of mechanical and nonmechanical agents. Bone Miner . 1987;2(2):73-85.
52. Yakar S, Canalis E, Sun H, et al. Serum IGF-1 determines skeletal strength by regulating sub-periosteal expansion and trait interactions. J Bone Miner Res . 2009;24(8):1481-1492.
53. Courtland HW, Elis S, Wu Y, et al. Serum IGF-1 affects skeletal acquisition in a temporal and compartment-specific manner. PLoS One . 2011;6(3):e14762.
54. Courtland HW, Kennedy OD, Wu Y, et al. Low levels of plasma IGF-1 inhibit intracortical bone remodeling during aging. Age (Dordr) . 2013;35(5):1691-1703.
55. Elis S, Wu Y, Courtland HW, et al. Increased serum IGF-1 levels protect the musculoskeletal system but are associated with elevated oxidative stress markers and increased mortality independent of tissue igf1 gene expression. Aging Cell . 2011;10(3):547-550.
56. McQuillan R, Eklund N, Pirastu N, et al. Evidence of inbreeding depression on human height. PLoS Genet. 2012;8(7):e1002655.